ICHOR Vascular was recently featured in Endovascular Today. The article, “ICHOR Vascular’s Reperfusion System Cleared by FDA,” discusses how the newly-approved Ichor system targets vascular occlusions by eliminating the need for surgery or drug therapies.
Highlights:
- ICHOR Vascular received FDA 510(k) clearance for the sale of its Ichor Panacea percutaneous reperfusion system, which is designed to treat organized thrombus and embolic events in the peripheral vasculature.
- Ichor is a one-size-fits-all system that replicates the standard of care of surgical embolectomy/thrombectomy but in a minimally invasive manner.
- “Ichor will be an extraordinary tool in the clot management toolbox due to its ability to handle the organized clot many physicians struggle to treat,” said Troy Long, MD.
Read the full article.
Posted in News